GLP-1 Based Therapies: Potential for Drug - Disease Interaction

Summary

This article discusses potential drug/disease interaction between the glucagon-like peptide-1 (GLP-1)-based diabetic therapies and pancreatitis (acute and chronic) and pancreatic cancer.

  • Gastrointestinal Cancers
  • Diabetes Mellitus
  • Gastrointestinal Cancers
  • Diabetes Mellitus
  • Endocrinology
  • Diabetes & Metabolic Syndrome
View Full Text